vs
Side-by-side financial comparison of CVR ENERGY INC (CVI) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
CVR ENERGY INC is the larger business by last-quarter revenue ($1.8B vs $1.1B, roughly 1.6× PERRIGO Co plc). CVR ENERGY INC runs the higher net margin — -6.1% vs -127.8%, a 121.7% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -7.0%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -1.4%).
CVR Energy Inc is a United States-based energy holding company operating two core segments: petroleum refining and nitrogen fertilizer manufacturing. It produces a wide range of products including gasoline, diesel, jet fuel, and agricultural fertilizers, primarily serving commercial, industrial and agricultural customers across North America.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CVI vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.1B |
| Net Profit | $-110.0M | $-1.4B |
| Gross Margin | -3.1% | 32.6% |
| Operating Margin | -5.3% | -116.0% |
| Net Margin | -6.1% | -127.8% |
| Revenue YoY | -7.0% | -2.5% |
| Net Profit YoY | -492.9% | -3093.9% |
| EPS (diluted) | $-1.09 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | $1.9B | $1.0B | ||
| Q2 25 | $1.8B | $1.1B | ||
| Q1 25 | $1.6B | $1.0B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $2.0B | $1.1B | ||
| Q1 24 | $1.9B | $1.1B |
| Q4 25 | $-110.0M | $-1.4B | ||
| Q3 25 | $374.0M | $7.5M | ||
| Q2 25 | $-114.0M | $-8.4M | ||
| Q1 25 | $-123.0M | $-6.4M | ||
| Q4 24 | $28.0M | $-44.4M | ||
| Q3 24 | $-124.0M | $-21.0M | ||
| Q2 24 | $21.0M | $-108.4M | ||
| Q1 24 | $82.0M | $2.0M |
| Q4 25 | -3.1% | 32.6% | ||
| Q3 25 | 28.8% | 36.1% | ||
| Q2 25 | -3.7% | 34.4% | ||
| Q1 25 | -5.5% | 37.6% | ||
| Q4 24 | 3.0% | 33.9% | ||
| Q3 24 | -3.9% | 37.2% | ||
| Q2 24 | 2.9% | 37.0% | ||
| Q1 24 | 8.6% | 33.1% |
| Q4 25 | -5.3% | -116.0% | ||
| Q3 25 | 26.3% | 7.0% | ||
| Q2 25 | -5.8% | 4.3% | ||
| Q1 25 | -8.0% | 4.5% | ||
| Q4 24 | 1.1% | 10.0% | ||
| Q3 24 | -6.2% | 7.4% | ||
| Q2 24 | 1.4% | -2.5% | ||
| Q1 24 | 6.6% | -5.1% |
| Q4 25 | -6.1% | -127.8% | ||
| Q3 25 | 19.2% | 0.7% | ||
| Q2 25 | -6.5% | -0.8% | ||
| Q1 25 | -7.5% | -0.6% | ||
| Q4 24 | 1.4% | -3.9% | ||
| Q3 24 | -6.8% | -1.9% | ||
| Q2 24 | 1.1% | -10.2% | ||
| Q1 24 | 4.4% | 0.2% |
| Q4 25 | $-1.09 | $-10.23 | ||
| Q3 25 | $3.72 | $0.05 | ||
| Q2 25 | $-1.14 | $-0.06 | ||
| Q1 25 | $-1.22 | $-0.05 | ||
| Q4 24 | $0.28 | $-0.32 | ||
| Q3 24 | $-1.24 | $-0.15 | ||
| Q2 24 | $0.21 | $-0.79 | ||
| Q1 24 | $0.81 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $511.0M | — |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $730.0M | $2.9B |
| Total Assets | $3.7B | $8.5B |
| Debt / EquityLower = less leverage | 2.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $511.0M | — | ||
| Q3 25 | $670.0M | $432.1M | ||
| Q2 25 | $596.0M | $454.2M | ||
| Q1 25 | $695.0M | $409.9M | ||
| Q4 24 | $987.0M | $558.8M | ||
| Q3 24 | $534.0M | $1.5B | ||
| Q2 24 | $586.0M | $542.8M | ||
| Q1 24 | $644.0M | $658.5M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $730.0M | $2.9B | ||
| Q3 25 | $840.0M | $4.4B | ||
| Q2 25 | $466.0M | $4.5B | ||
| Q1 25 | $580.0M | $4.4B | ||
| Q4 24 | $703.0M | $4.3B | ||
| Q3 24 | $675.0M | $4.6B | ||
| Q2 24 | $849.0M | $4.5B | ||
| Q1 24 | $879.0M | $4.7B |
| Q4 25 | $3.7B | $8.5B | ||
| Q3 25 | $4.0B | $10.1B | ||
| Q2 25 | $4.0B | $10.1B | ||
| Q1 25 | $4.3B | $9.8B | ||
| Q4 24 | $4.3B | $9.6B | ||
| Q3 24 | $3.9B | $11.2B | ||
| Q2 24 | $4.0B | $10.4B | ||
| Q1 24 | $4.1B | $10.6B |
| Q4 25 | 2.40× | — | ||
| Q3 25 | 2.17× | — | ||
| Q2 25 | 3.97× | — | ||
| Q1 25 | 3.29× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.79× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $0 | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | 3.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $0 | $175.4M | ||
| Q3 25 | $163.0M | $51.7M | ||
| Q2 25 | $176.0M | $75.9M | ||
| Q1 25 | $-195.0M | $-64.5M | ||
| Q4 24 | $98.0M | $312.6M | ||
| Q3 24 | $48.0M | $42.2M | ||
| Q2 24 | $81.0M | $9.5M | ||
| Q1 24 | $177.0M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | $125.0M | $29.8M | ||
| Q2 25 | $135.0M | $56.7M | ||
| Q1 25 | $-246.0M | $-90.0M | ||
| Q4 24 | $43.0M | $274.9M | ||
| Q3 24 | $14.0M | $15.1M | ||
| Q2 24 | $38.0M | $-18.9M | ||
| Q1 24 | $130.0M | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | 6.4% | 2.9% | ||
| Q2 25 | 7.7% | 5.4% | ||
| Q1 25 | -14.9% | -8.6% | ||
| Q4 24 | 2.2% | 24.2% | ||
| Q3 24 | 0.8% | 1.4% | ||
| Q2 24 | 1.9% | -1.8% | ||
| Q1 24 | 7.0% | -2.4% |
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 2.0% | 2.1% | ||
| Q2 25 | 2.3% | 1.8% | ||
| Q1 25 | 3.1% | 2.4% | ||
| Q4 24 | 2.8% | 3.3% | ||
| Q3 24 | 1.9% | 2.5% | ||
| Q2 24 | 2.2% | 2.7% | ||
| Q1 24 | 2.5% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.44× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.86× | — | ||
| Q1 24 | 2.16× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVI
| Petroleum Segment | $1.6B | 91% |
| Product UAN | $64.0M | 4% |
| Product Ammonia | $51.0M | 3% |
| Renewables Diesel | $27.0M | 1% |
| Product Urea Products | $8.0M | 0% |
| Renewable Fuel Credits | $7.0M | 0% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
